Fat embolism--some clinical observations and a review of controversial aspects.
D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D001927:Brain Diseases / Q000209:etiology; D002994:Clofibrate / Q000627:therapeutic use; D003911:Dextrans / Q000627:therapeutic use; D004620:Embolism, Fat / Q000150:complications / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology; D000431:Ethanol / Q000627:therapeutic use; D005260:Female; D005264:Femoral Fractures / Q000150:complications; D005593:Fracture Fixation, Internal; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D000860:Hypoxia / Q000209:etiology; D008168:Lung / Q000503:physiopathology; D008297:Male; D010100:Oxygen / Q000097:blood
D000305:Adrenal Cortex Hormones; D000317:Adrenergic alpha-Antagonists; D003911:Dextrans; D000431:Ethanol; D006493:Heparin; D002994:Clofibrate; D010100:Oxygen